-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form
Original Research
(1419) Views (624) Full article downloads
Authors: Nancy Kline Leidy, Ann Knebel
Published Date November 2010
Volume 2010:5 Pages 415 - 423
DOI: http://dx.doi.org/10.2147/COPD.S13389
Nancy Kline Leidy1, Ann Knebel21Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA; 2Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC, USA
Purpose: The 65-item Functional Performance Inventory (FPI), developed to quantify functional performance in patients with chronic obstructive pulmonary disease (COPD), has been shown to be reliable and valid. The purpose of this study was to create a shorter version of the FPI while preserving the integrity and psychometric properties of the original.
Patients and methods: Secondary analyses were performed on qualitative and quantitative data used to develop and validate the FPI long form. Seventeen men and women with COPD participated in the qualitative work, while 154 took part in the mail survey; 54 completed 2-week reproducibility assessment, and 40 relatives contributed validation data. Following a systematic process of item reduction, performance properties of the 32-item short form (FPI-SF) were examined.
Results: The FPI-SF was internally consistent (total scale α = 0.93; subscales: 0.76–0.89) and reproducible (r = 0.88; subscales: 0.69–0.86). Validity was maintained, with significant (P < 0.001) correlations between the FPI-SF and the Functional Status Questionnaire (activities of daily living, r = 0.71; instrumental activities of daily living, r = 0.73), Duke Activity Status Index (r = 0.65), Bronchitis-Emphysema Symptom Checklist (r = -0.61), Basic Need Satisfaction Inventory (r = 0.61) and Cantril’s Ladder of Life Satisfaction (r = 0.63), and Katz Adjustment Scale for Relatives (socially expected activities, r = 0.51; free-time activities, r = -0.49, P < 0.01). The FPI-SF differentiated patients with an FEVl% predicted greater than and less than 50% (t = 4.26, P < 0.001), and those with severe and moderate levels of perceived severity and activity limitation (t = 9.91, P < 0.001).
Conclusion: Results suggest the FPI-SF is a viable alternative to the FPI for situations in which a shorter instrument is desired. Further assessment of the instrument’s performance properties in new samples of patients with COPD is warranted.
Keywords: functional status, health outcomes, activities of daily living, COPD, patient-reported outcomes, chronic pulmonary disease, health-related quality of life
Readers of this article also read:
Budesonide/formoterol combination in COPD: a US perspective
Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
Development and implementation of treadmill exercise testing protocols in COPD
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors
Improving adherence with inhaler therapy in COPD
Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients
Association between lung function and exacerbation frequency in patients with COPD
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




